Projects per year
Fingerprint
Dive into the research topics where Tomasz (Tom) Beer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
- 8 Finished
-
Resistance and Response Mechanisms to Prostate Cancer Therapy
5/1/06 → 3/31/11
Project: Research project
-
-
-
-
CALCITRIOL IN RECURRENT PROSTATE CANCER
Beer, T. (. & Henner, W.
9/30/99 → 9/29/03
Project: Research project
Research output
-
Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations
Schmid, S., Omlin, A., Higano, C., Sweeney, C., Martinez Chanza, N., Mehra, N., Kuppen, M. C. P., Beltran, H., Condeduca, V., Vargas Pivato de Almeida, D., Cotait Maluf, F., Oh, W. K., Tsao, C. K., Sartor, O., Ledet, E., Di Lorenzo, G., Yip, S. M., Chi, K. N., Bianchini, D., De Giorgi, U. & 16 others, , Oct 1 2020, In: JAMA Network Open. 3, 10, p. e2021692Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone
Graff, J. N., Beer, T. M., Alumkal, J. J., Slottke, R. E., Redmond, W. L., Thomas, G. V., Thompson, R. F., Wood, M. A., Koguchi, Y., Chen, Y., Latour, E., Bergan, R. C., Drake, C. G. & Moran, A. E., Jul 2 2020, In: Journal for immunotherapy of cancer. 8, 2, e00642.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Association between New Unconfirmed Bone Lesions and Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: Secondary Analysis of the PREVAIL and AFFIRM Randomized Clinical Trials
Armstrong, A. J., Al-Adhami, M., Lin, P., Parli, T., Sugg, J., Steinberg, J., Tombal, B., Sternberg, C. N., De Bono, J., Scher, H. I. & Beer, T. M., Feb 2020, In: JAMA Oncology. 6, 2, p. 217-225 9 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Autoantibody landscape in patients with advanced prostate cancer
Chen, W. S., Haynes, W. A., Waitz, R., Kamath, K., Vega-Crespo, A., Shrestha, R., Zhang, M., Foye, A., Carretero, I. B., Garcilazo, I. P., Zhang, M., Zhao, S. G., Sjöström, M., Quigley, D. A., Chou, J., Beer, T. M., Rettig, M., Gleave, M., Evans, C. P., Lara, P. & 11 others, , Dec 2020, In: Clinical Cancer Research. 26, 23, p. 6204-6214 11 p.Research output: Contribution to journal › Article › peer-review
-
Copy number loss of 17q22 is associated with enzalutamide resistance and poor prognosis in metastatic castration-resistant prostate cancer
Guan, X., Sun, D., Lu, E., Urrutia, J. A., Reiter, R. E., Rettig, M., Evans, C. P., Lara, P., Gleave, M., Beer, T. M., Thomas, G. V., Huang, J., Aggarwal, R. R., Quigley, D. A., Foye, A., Chen, W. S., Youngren, J., Weinstein, A. S., Stuart, J. M., Feng, F. Y. & 3 others, , Sep 2020, In: Clinical Cancer Research. 26, 17, p. 4616-4624 9 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations